Clinical Outcome after Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Central Retinal Vein Occlusion

Publisher： Karger

E-ISSN： 1423-0259|54|3|150-156

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.54, Iss.3, 2015-09, pp. : 150-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rapid Resolution of Macular Edema Associated with Central Retinal Vein Occlusion Using Ranibizumab after Failure with Multiple Bevacizumab Injections

By Labriola Leanne T.   Sadda SriniVas R.  

Seminars in Ophthalmology, Vol. 26, Iss. 6, 2011-11 ,pp. : 387-391

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome

By  

Ophthalmic Research, Vol. 55, Iss. 1, 2016-0 ,pp. : 10-18

Karger

Access to resources Recommend Favorite

Intravitreal aflibercept use in the treatment of macular edema from central retinal vein occlusion

By Carle Michelle V   Chu Thomas G   Tabandeh Homayoun   Boyer David S  

Expert Review of Ophthalmology, Vol. 8, Iss. 3, 2013-06 ,pp. : 227-235

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparison of Intravitreal Ranibizumab, Aflibercept, and Dexamethasone Implant after Bevacizumab Failure in Macular Edema Secondary to Retinal Vascular Occlusions

By  

Ophthalmologica, Vol. 238, Iss. 1-2, 2017-05 ,pp. : 110-118

Karger

Access to resources Recommend Favorite

Intravitreous Bevacizumab Treatment for Macular Edema due to Central Retinal Vein Occlusion

By Axer-Siegel Ruth   Dotan Assaf   Mimouni Karin   Bor Elite   Weinberger Dov   Bourla Dan Haim  

Current Eye Research, Vol. 37, Iss. 9, 2012-09 ,pp. : 818-822

Informa Healthcare

Access to resources Recommend Favorite